34728295|t|Alzheimer's disease related biomarkers in bipolar disorder - A longitudinal one-year case-control study.
34728295|a|INTRODUCTION: Bipolar disorder (BD) is a heterogeneous mental disorder characterized by recurrent relapses of affective episodes: Subgroups of patients with BD have cognitive deficits, and an increased risk of dementia. METHODS: This prospective, longitudinal, one-year follow-up, case-control study investigated biomarkers for AD and neurodegenerative diseases, namely: cerebrospinal fluid (CSF) amyloid beta (Abeta) isoforms and ratios (Abeta42, Abeta40, Abeta38), CSF soluble amyloid precursor protein (sAPP) alpha and beta, CSF total (t-tau) and phosphorylated tau (p-tau), CSF neurofilament-light (NF-L), CSF neurogranin (NG), plasma-isoforms Abeta42 and Abeta40, plasma-tau, plasma-NF-L, and serum S100B, in patients with BD (N = 62, aged 18-60) and gender-and-age-matched healthy control individuals (N = 40). CSF and plasma/serum samples were collected at baseline, during and after an affective episode, if it occurred, and after a year. Data were analyzed in mixed models. RESULTS: Levels of CSF Abeta42 decreased in patients with BD who had an episode during follow-up (BD-E) (N = 22) compared to patients without an episode (BD-NE) (N = 25) during follow-up (P = 0.002). Stable levels were seen for all other markers in BD-E compared to BD-NE during the one-year follow-up. We found no statistically significant differences between patients with BD and HC at T0 and T3 for Abeta42, Abeta40, Abeta38, Abeta42/38, Abeta42/40, sAPPalpha, sAPPbeta, t-tau, p-tau, p-tau /t-tau, NF-L, NG in CSF and further Abeta40, Abeta42, Abeta42/40, t-tau, NF-L in plasma, S100B in serum, and APOE-status. Furthermore, all 18 biomarkers were stable in HC during the one-year follow-up from T0 to T3. CONCLUSION: A panel of biomarkers of Alzheimer's and neurodegeneration show no differences between patients with BD and HC. There were abnormalities of amyloid production/clearance during an acute BD episode. The abnormalities mimic the pattern seen in AD namely decreasing CSF Abeta42 and may suggest an association with brain amyloidosis.
34728295	0	19	Alzheimer's disease	Disease	MESH:D000544
34728295	42	58	bipolar disorder	Disease	MESH:D001714
34728295	119	135	Bipolar disorder	Disease	MESH:D001714
34728295	137	139	BD	Disease	MESH:D001714
34728295	160	175	mental disorder	Disease	MESH:D001523
34728295	248	256	patients	Species	9606
34728295	262	264	BD	Disease	MESH:D001714
34728295	270	288	cognitive deficits	Disease	MESH:D003072
34728295	315	323	dementia	Disease	MESH:D003704
34728295	433	435	AD	Disease	MESH:D000544
34728295	440	466	neurodegenerative diseases	Disease	MESH:D019636
34728295	502	514	amyloid beta	Gene	351
34728295	516	521	Abeta	Gene	351
34728295	544	551	Abeta42	Gene	351
34728295	670	673	tau	Gene	4137
34728295	687	706	neurofilament-light	Gene	4747
34728295	708	712	NF-L	Gene	4747
34728295	719	730	neurogranin	Gene	4900
34728295	732	734	NG	Gene	4900
34728295	753	760	Abeta42	Gene	351
34728295	781	784	tau	Gene	4137
34728295	793	797	NF-L	Gene	4747
34728295	809	814	S100B	Gene	6285
34728295	819	827	patients	Species	9606
34728295	833	835	BD	Disease	MESH:D001714
34728295	999	1016	affective episode	Disease	MESH:C580065
34728295	1111	1118	Abeta42	Gene	351
34728295	1132	1140	patients	Species	9606
34728295	1146	1148	BD	Disease	MESH:D001714
34728295	1186	1188	BD	Disease	MESH:D001714
34728295	1213	1221	patients	Species	9606
34728295	1242	1244	BD	Disease	MESH:D001714
34728295	1337	1339	BD	Disease	MESH:D001714
34728295	1354	1356	BD	Disease	MESH:D001714
34728295	1449	1457	patients	Species	9606
34728295	1463	1465	BD	Disease	MESH:D001714
34728295	1490	1497	Abeta42	Gene	351
34728295	1517	1527	Abeta42/38	Gene	351
34728295	1529	1539	Abeta42/40	Gene	351
34728295	1590	1594	NF-L	Gene	4747
34728295	1596	1598	NG	Gene	4900
34728295	1627	1634	Abeta42	Gene	351
34728295	1636	1646	Abeta42/40	Gene	351
34728295	1655	1659	NF-L	Gene	4747
34728295	1671	1676	S100B	Gene	6285
34728295	1691	1695	APOE	Gene	348
34728295	1835	1868	Alzheimer's and neurodegeneration	Disease	MESH:D000544
34728295	1897	1905	patients	Species	9606
34728295	1911	1913	BD	Disease	MESH:D001714
34728295	1950	1957	amyloid	Disease	MESH:C000718787
34728295	1995	1997	BD	Disease	MESH:D001714
34728295	2051	2053	AD	Disease	MESH:D000544
34728295	2076	2083	Abeta42	Gene	351
34728295	2120	2137	brain amyloidosis	Disease	MESH:D000686
34728295	Association	MESH:D000544	4747
34728295	Association	MESH:D001714	348
34728295	Association	MESH:D001714	351

